Registration Is Now Open For The Tribe Public Webinar Event On November 30, 2021 “A Town Hall Q&A Event With Atossa Therapeutics Management Team”GlobeNewsWire • 11/24/21
Atossa Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/15/21
Atossa Therapeutics CEO Dr. Steven Quay Emphasizes Importance of Breast Cancer Screening During Breast Cancer Awareness MonthGlobeNewsWire • 10/21/21
Atossa Therapeutics Begins Enrollment in Clinical Study of AT-H201 in AustraliaGlobeNewsWire • 09/30/21
Atossa Therapeutics: Diversification Into COVID Makes Sense In A Variants WorldSeeking Alpha • 09/22/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Atossa Therapeutics, Inc. - ATOSNewsfile Corp • 09/13/21
Atossa Therapeutics Adjourns Special Stockholder Meeting to October 7, 2021 to Allow Additional Time to VoteGlobeNewsWire • 09/07/21
Atossa Therapeutics Receives Approval from the Swedish Ethics Review Authority to Initiate a Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density in SwedenGlobeNewsWire • 09/02/21
Atossa Therapeutics Stock Lost Its Covid Mojo, and Its Pipeline Fails To ImpressInvestorPlace • 08/31/21
Atossa Therapeutics Announces Second Quarter 2021 Financial Results - Provides Corporate Update and Information about Upcoming Stockholder MeetingGlobeNewsWire • 08/13/21